231 related articles for article (PubMed ID: 29464314)
1. Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.
Marchi LF; Paoliello-Paschoalato AB; Oliveira RDR; Azzolini AECS; Kabeya LM; Donadi EA; Lucisano-Valim YM
Rheumatol Int; 2018 Jun; 38(6):1043-1052. PubMed ID: 29464314
[TBL] [Abstract][Full Text] [Related]
2. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
[TBL] [Abstract][Full Text] [Related]
3. Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease.
Crockard AD; Thompson JM; McBride SJ; Edgar JD; McNeill TA; Bell AL
Clin Immunol Immunopathol; 1992 Nov; 65(2):135-42. PubMed ID: 1395130
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
5. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
Wiland P; Głowska A; Chlebicki A; Szechiński J
Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
[TBL] [Abstract][Full Text] [Related]
7. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
8. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis.
Ingegnoli F; Fantini F; Griffini S; Soldi A; Meroni PL; Cugno M
Clin Exp Rheumatol; 2010; 28(2):254-7. PubMed ID: 20483049
[TBL] [Abstract][Full Text] [Related]
10. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
[TBL] [Abstract][Full Text] [Related]
11. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.
Jones J; Laffafian I; Cooper AM; Williams BD; Morgan BP
Br J Rheumatol; 1994 Aug; 33(8):707-12. PubMed ID: 8055195
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
[TBL] [Abstract][Full Text] [Related]
13. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.
van der Bijl AE; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ten Wolde S; Han KH; van Krugten MV; Allaart CF; Breedveld FC; Dijkmans BA
Arthritis Rheum; 2007 Jul; 56(7):2129-34. PubMed ID: 17599726
[TBL] [Abstract][Full Text] [Related]
14. Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab.
Dain L; Braun-Moscovici Y; Baum E; Nahir AM; Hoffer E
Clin Exp Rheumatol; 2006; 24(1):38-44. PubMed ID: 16539817
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
16. DNA damage increase in peripheral neutrophils from patients with rheumatoid arthritis is associated with the disease activity and the presence of shared epitope.
Martelli-Palomino G; Paoliello-Paschoalato AB; Crispim JC; Rassi DM; Oliveira RD; Louzada P; Lucisano-Valim YM; Donadi EA
Clin Exp Rheumatol; 2017; 35(2):247-254. PubMed ID: 27908303
[TBL] [Abstract][Full Text] [Related]
17. The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis.
Kaundal U; Khullar A; Leishangthem B; Jain S; Dhooria A; Saikia B; Dhir V
Clin Exp Rheumatol; 2021; 39(3):479-486. PubMed ID: 32573414
[TBL] [Abstract][Full Text] [Related]
18. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
Mack ME; Hsia E; Aletaha D
Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
[TBL] [Abstract][Full Text] [Related]
20. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Clin Exp Rheumatol; 2006; 24(5):529-33. PubMed ID: 17181921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
